Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Liabilities and Shareholders Equity: 2012-2024

Historic Liabilities and Shareholders Equity for Veracyte (VCYT) over the last 13 years, with Dec 2024 value amounting to $1.3 billion.

  • Veracyte's Liabilities and Shareholders Equity rose 7.28% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 billion, marking a year-over-year increase of 10.43%. This contributed to the annual value of $1.3 billion for FY2024, which is 16.60% up from last year.
  • Per Veracyte's latest filing, its Liabilities and Shareholders Equity stood at $1.3 billion for FY2024, which was up 16.60% from $1.1 billion recorded in FY2023.
  • Over the past 5 years, Veracyte's Liabilities and Shareholders Equity peaked at $1.3 billion during FY2024, and registered a low of $457.2 million during FY2020.
  • In the last 3 years, Veracyte's Liabilities and Shareholders Equity had a median value of $1.2 billion in 2022 and averaged $1.2 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 159.83% in 2021, then declined by 3.59% in 2023.
  • Yearly analysis of 5 years shows Veracyte's Liabilities and Shareholders Equity stood at $457.2 million in 2020, then soared by 159.83% to $1.2 billion in 2021, then declined by 2.64% to $1.2 billion in 2022, then dropped by 3.59% to $1.1 billion in 2023, then rose by 16.60% to $1.3 billion in 2024.